Badgley, Phelps & Bell’s Novo Nordisk NVO Stock Holding History

Badgley, Phelps & Bell’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$849K	Sell	20,272 -1,540	-7%	-$59.7K	0.03%	140
2021 Q1	$735K	Sell	21,812 -900	-4%	-$32.1K	0.03%	140
2020 Q4	$793K	Buy	22,712 +2,050	+10%	+$70.9K	0.03%	140
2020 Q3	$717K	Hold	20,662	–	–	0.04%	138
2020 Q2	$676K	Hold	20,662	–	–	0.04%	131
2020 Q1	$622K	Hold	20,662	–	–	0.04%	122
2019 Q4	$598K	Buy	20,662 +450	+2%	+$12.5K	0.03%	137
2019 Q3	$522K	Sell	20,212 -3,400	-14%	-$86K	0.03%	140
2019 Q2	$603K	Sell	23,612 -1,300	-5%	-$32.1K	0.04%	137
2019 Q1	$652K	Hold	24,912	–	–	0.04%	130
2018 Q4	$574K	Sell	24,912 -268	-1%	-$5.96K	0.04%	130
2018 Q3	$593K	Buy	25,180 +400	+2%	+$9.76K	0.04%	134
2018 Q2	$571K	Sell	24,780 -500	-2%	-$11.9K	0.04%	135
2018 Q1	$623K	Buy	25,280 +800	+3%	+$21K	0.04%	129
2017 Q4	$657K	Buy	+24,480	New	+$623K	0.05%	130

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Badgley, Phelps & Bell's NVO Position: Q2 2021 in Review

Badgley, Phelps & Bell reduced its Novo Nordisk (NVO) stake by 7.1% in Q2 2021, selling an estimated $59.7K and leaving 20,272 shares worth $849K. The position accounts for 0.03% of the portfolio, ranked #140.

Badgley, Phelps & Bell first reported a position in NVO in Q4 2017 and has held it in 15 quarters since. 735 funds tracked by Wall St. Rank hold NVO as of Q2 2021.

Badgley, Phelps & Bell held 20,272 shares of Novo Nordisk worth $849K as of Q2 2021.
Badgley, Phelps & Bell sold 1,540 Novo Nordisk shares in Q2 2021, an estimated $59.7K.
Novo Nordisk made up 0.03% of Badgley, Phelps & Bell's portfolio in Q2 2021, its #140 holding.
Badgley, Phelps & Bell first reported a position in Novo Nordisk in Q4 2017 and has held it in 15 quarters since.
735 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2021.

Based on Badgley, Phelps & Bell's 13F filing for Q2 2021, filed 28 Jul 2021.